comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-04 04:43:14 - browse：1921

ADAM FEUERSTEIN/STAT

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here.

CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Argenx drug significantly slows progression of nerve disorder

entertainment

leisure time

WSS

Involuntary treatment for addiction doesn't work

Congress: Eradicate hepatitis C and reduce the deficit

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Senate panel eyes new effort on drug shortages

Europe sees delivery challenges ahead on Alzheimer's therapies

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

Heart attack and stroke risk calculators need revising

Liquid biopsy for lung cancer is launched by Delfi

Trump demands the U.S. pay no more for drugs than other countries … again

Europe sees delivery challenges ahead on Alzheimer's therapies

Duchenne breakthrough therapy leaves behind pioneering families

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

The high cost of giving birth even with insurance

Histogen: Failed biotech offers rare public look inside

At least 13 dead in Texas as scorching temps continue

VC firm General Catalyst wants to buy a health system

focus

3 questions for the future of Biden's cancer moonshot

FDA authorizes Novavax’s updated Covid

Does aspartame cause cancer? What new WHO guidance says

Physician executives need more than on

Was Amgen transparent enough on FDA's concern on cancer drug?

FDA authorizes Novavax’s updated Covid

entertainment

entertainment

leisure time

hotspot